Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Lumateperone"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundLumateperone has been approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia in adults since 2019, however, there is still a lack of data report on adverse reactions in real-world settings. Conducting data min
Externí odkaz:
https://doaj.org/article/bffbf82684654491abf2eed659e3191d
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveLumateperone, a novel antipsychotic drug that was granted by the Food and Drug Administration (FDA) approval in December 2019, remains insufficiently explored for its adverse event profile. This study used the FDA Adverse Event Reporting Sys
Externí odkaz:
https://doaj.org/article/87d8311d833746e1972c9ce327533ab3
Publikováno v:
Brain Sciences, Vol 13, Iss 12, p 1641 (2023)
Lumateperone (also known as ITI-007 or ITI-722) represents a novel second-generation medication characterized by a favorable safety and tolerability profile. This is attributed to its notable selectivity for D2 receptors within specific regions of th
Externí odkaz:
https://doaj.org/article/432e13941ecb4ad9929c1e33e13eba77
Autor:
Octavian Vasiliu
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Exploring the possible correlations between gene variations and the clinical effects of the new-generation antipsychotics is considered essential in the framework of personalized medicine. It is expected that pharmacogenetic data will be useful for i
Externí odkaz:
https://doaj.org/article/d06a4b7b35c44c31839225ffc4f20a41
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Octavian Vasiliu
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Clozapine is considered « the golden standard » for the management of treatment-resistant schizophrenia, but many patients do not present adequate responsivity even to this antipsychotic. If we add the need to strictly monitor the hematologic and c
Externí odkaz:
https://doaj.org/article/571a374e078148d1b09719c3ee056382
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Brain Sciences, Vol 13, Iss 8, p 1193 (2023)
Schizophrenia is a chronic neuropsychiatric syndrome that significantly impacts daily function and quality of life. All of the available guidelines suggest a combined treatment approach with pharmacologic agents and psychological interventions. Howev
Externí odkaz:
https://doaj.org/article/a3e34d977ec542b78108304ebfbe2d9c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Muhammad Muzammal, Ahmad Firoz, Hani Mohammed Ali, Arshad Farid, Muzammil Ahmad Khan, Khalid Rehman Hakeem
Publikováno v:
Applied Sciences, Vol 12, Iss 17, p 8820 (2022)
The Ebola virus outbreak in Africa is an unparalleled risk to society and to human health. Interventions that utilize the host cell receptor TIM-1 and the viral spike protein (S-protein) can be considered effective and suitable treatments. Initially,
Externí odkaz:
https://doaj.org/article/5625e4f726e34a07a4fe14f4e920ba4e